---
title: Risk Analysis
---

This was a research where industry analysis of the Indian Pharmaceutical sector was done with a focus on Lupin Pharmaceuticals. We analyzed the riskiness across the Sector and Lupin by calculating betas using regression, unlevered betas & IERP. Correlations between the risk factors was also examined. We also looked at the effects to market news and dividend announcements on the stock price.